4//SEC Filing
Michelon Francois Roger 4
Accession 0001209191-22-021622
CIK 0001681682other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 5:15 PM ET
Size
5.4 KB
Accession
0001209191-22-021622
Insider Transaction Report
Form 4
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2022-03-28+713,132→ 713,132 totalExercise: $0.38Exp: 2032-03-28→ Common Stock (713,132 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001691470
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 5:15 PM ET
- Size
- 5.4 KB